Biggest News Aggregation in the World
📰 Special Access Program News

Page 11 - Special Access Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Special Access Program. Real-time updates on events, politics, business and more.

ANAVEX®2-73 (blarcamesine) Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome

Health Canada Special Access Program Authorizes ANAVEX®2-73 for patients after successful completion of Open-Label Extension study Granting of requests are also ongoing in United Kingdom and... | June 15, 2023
United Kingdom Sabrina Millson Christopheru Missling Andrewj Barwicki Research Business Development Ontario Rett Syndrome Association

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Core One Labs Inc.: Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy

VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that its wholly-owned subsidiaries
British Columbia United Kingdom Joel Shacker Health Canada Special Access Program Core One Labs Inc View Biosciences Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science